conferenceseries materials chemistry 2017 conferenceseries ......conferenceseries.com materials...
TRANSCRIPT
Materials Chemistry 2017conferenceseries.com
Conference SeriesOne Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA
P: +1-702-508-5200, F: +1-650-618-1417Email: [email protected] / [email protected]
Tentative Programconferenceseries.com
Theme: “Fighting Flu & Infections with Innovative Techniques”
**For Available Speaker Slots**[email protected] / [email protected]
Flu and Emerging Infectious Diseases3rd International Conference on
November 07-08, 2018 | Alabama, USA
19+ Interactive Sessions 75+ Plenary
Lectures15+ Keynote Lectures 5+ Workshops
Program at a Glance
http://flu.conferenceseries.com/
e-mail us: [email protected], [email protected]
Alabama is a state in the south eastern region of the United States. It is bordered by Tennessee
to the north, Georgia to the east, Florida and the Gulf of Mexico to the south, and Mississippi to the
west. Alabama is the 30th largest by area and the 24th-most populous of the U.S. states. With a total
of 1,500 miles (2,400 km) of inland waterways, Alabama has among the most of any state.
An estimated 20 million tourists visit the state each year. Over 100,000 of these are from other
countries, including from Canada, the United Kingdom, Germany and Japan. The major cities
surrounding the place are Birmingham, Huntsville, Montgomery and Mobile. In the history of Alabama,
no city has played a major role than that of Montgomery. Battles Wharf, Botanical gardens, Cheaha
State park, Chewacla Falls, Downtown mobile, Florence, Fort Payne Depot Museum, Gulf Shores,
Lake Martin, The Old Mill on Shades Creek, Neversink Pit Sinkhole and many more interesting places
have made the place a best tourist spot.
America’s Finest City also showcases many popular attractions for the whole family to enjoy.
Some of these include Battles Wharf, Cheaha State park, Chewacla Falls, Downtown mobile, Fort
Payne Depot Museum, Florence, Gulf Shores, Lake Martin, Neversink Pit Sinkhole, The Old Mill on
Shades Creek.
We look forward to meet you in Alabama !
About Alabama
Flu and Infectious Diseases 2018
For detailed sessions & sub-sessions, kindly visit:https://flu.conferenceseries.com/call-for-abstracts.phpSubmit your Abstract Online: https://flu.conferenceseries.com/abstract-submission.phpRegister Online: https://flu.conferenceseries.com/registration.php
VenueUpdating soon...
Page 4
• Emerging Infectious Diseases
• Geographic Distribution And Transmission of Emerging infectious disease
• Factors in the Emergence of Infectious Diseases
• Host Defenses Against Emerging Infectious Diseases
• Public Health Measures to Prevent Emerging Infectious Diseases
• Treatment of Emerging Infectious Diseases
• Flu /Influenza Virus
• Antigenic Variation of Flu/ Influenza Virus
• Pathology of Flu/ Influenza virus
• Symptoms And Treatment Of Flu/Influenza Virus
• Flu/ Influenza vaccines : Current And Novel Approach
• Flu/ Influenza Vaccines And Vaccination
• Antivirals and Therapeutics for Flu disease
• Epidemology and Public Health of Flu/ Influenza
• Flu Vaccines And Case Reports Of Flu
• Flu Virus -Advancements in Detection & Differentiation
Conference Highlights
e-mail us: [email protected] [email protected]
http://rarediseases.conferenceseries.com/
Important Links:
For more about the Tracks click here to the following link
https://flu.conferenceseries.com/call-for-abstracts.php
Flu and Infectious Diseases 2018
256th OMICS International Conference
June 08-10, 2015 Chicago, USAInternational Conference on Flu
OMICS International Conferences5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA Phone: +1-650-268-9744, Fax: +1-650-618-1414
Email: [email protected]; [email protected]
Scientific Program
Media Partners
08:00-09:00 Registrations
Opening Ceremony09:00-09:30
Day 1 June 8, 2015
Group PhotoTrack 1: Flu Vaccine & VaccinationTrack 4: Molecular Biology of Influenza VirusesTrack 9: Influenza and AntiviralsTrack 10: Therapeutic Approaches and Targets for Viral InfectionSession Chair: Pamuk Bilsel, FluGen, Inc, USASession Co-Chair: Masayuki Noguchi, Hokkaido University, Japan
Session Introduction
11:25-11:45Title: A novel approach for inhibiting progression of flu virus infection at early stages of the disease by inhalation of alpla-Gal/SA liposomesUri Galili, UMass Medical School, USA
11:45-12:05Title: M2SR, a single replication universal flu vaccinePamuk Bilsel, FluGen, Inc, USA
12:05-12:25Title: Acute allergic inflammation protects against influenza A virus induced morbidity in miceAmali E Samarasinghe, University of Tennessee Health Science Center, USA
12:25-12:45Title: Identification of critical residues in the hemagglutinin (HA) that impact the replication, stability and immunogenicity of live attenuated influenza vaccinesZhongying Chen, MedImmune / AstraZeneca, USA
12:45-13:05Title: Influenza virus-like particle vaccines elicit protective immunity in the early stage of vaccinationFu Shi Quan, Kyung Hee University School of Medicine, Korea
Lunch Break 13:05-13:45 @ Athens
13:45-14:05Title: Host factors for influenza virus replicationMichael M C Lai, China Medical University, Taiwan
14:05-14:25Title: Systems biology studies to dissect the regulatory mechanisms of antiviral immunityVladimir Litvak, University of Massachusetts Medical School, USA
14:25-14:45Title: Subversion of autophagy by viral LC3 interacting regionsRupert Beale, University of Cambridge, UK
14:45-15:05Title: A simple and rapid assay for determination of susceptibility of influenza virus to neuraminidase inhibitorsX James Li, Cellex Incorporated, USA
Networking & Refreshments Break 15:05-15:25 @ Foyer
15:25-15:45Title: Activation of protective innate-adaptive immunity duo for conferring rapid-sustained-broad protection of vaccines against influenzaDe-chu Christopher Tang, VaxDome LLC, USA
15:45-16:05Title: In vivo Veritas: Influenza vaccination triggers the rapid differentiation of monocytes into dendritic cells in vivo in humansYun-Chi Chen, Morgan State University, USA
Keynote Forum09:30-09:35 Introduction09:35-10:05 Scott Umlauf VaxInnate Corporation, USA10:05-10:35 Vadim Bichko ChemDiv, Inc, USA
10:55-11:25 Joshua DiNapoli Sanofi Pasteur Biologics LLC, USA
Vienna
Networking & Refreshments Break 10:35-10:55 @ Foyer
16:05-16:25Title: Changes in the prevalence of influenza-like illness and influenza vaccine uptake among hajj pilgrims: A 10-year retrospective analysis of dataOsamah Barasheed, University of Sydney, Australia
16:25-16:45Title: Characterization and immunogenicity in mice of rececombinant influenza haemagglutinins produced in Leishmania tarentolaeIsabelle Legastelois, Sanofi Pasteur, France
Panel Discussion
Day 2 June 9, 2015Vienna
Keynote Forum09:30-10:00 Rangaraj Selvarangan Children’s Mercy Hospital, USA
10:00-10:30 Ming Zhang University of Georgia, USA
Networking & Refreshments Break 10:30-10:50 @ AthensTrack 2: Current Focus in Flu ResearchTrack 6: Threat of Cross-Species StrainsTrack 7: Influenza Strains: Detection and DifferentiationTrack 8: Influenza Co-infectionSession Chair: Rob Lambkin-Williams, hVIVO, UKSession Co-Chair: Benicio Gutiérrez-Doña, Universidad Estatal a Distancia, Costa Rica
Session Introduction
10:50-11:10Title: Structural equation modeling of male/female handwashing behaviors during the a (H1N1) pandemic influenza in 2009-2010Benicio Gutiérrez-Doña, Universidad Estatal a Distancia, Costa Rica
11:10-11:30Title: Neutralizing antibodies directed against the influenza hemagglutinin head domain are more potent in vivo than those directed against the broadly conserved stem domainJoshua DiNapoli, Sanofi Pasteur Biologics LLC, USA
11:30-11:50Title: USDA swine influenza surveillance programAlicia Janas-Martindale, United States Department of Agriculture, USA
11:50-12:10Title: Manifestations of influenza in Romania Angelica Constanta Visan, Carol Davila University of Medicine and Pharmacy, Romania
12:10-12:30Title: Accelerating influenza research; Vaccines, antivirals, immunodulators and monoclonal antibodies. The manufacture of a new H3N2 virus for the human viral challenge modelRob Lambkin-Williams, hVIVO, UK
Lunch Break 12:30-13:10 @ Athens
13:10-13:30Title: Survey of causative agents for acute respiratory infections among patients in Khartoum- State, Sudan, 2010-2011Khalid A Enan, Central Laboratory, Sudan
Workshop
13:30-15:00Title: Designing effective flu vaccines against a broad-spectrum of influenza virusesPamuk Bilsel, FluGen, Inc, USA
Networking & Refreshments Break 15:00-15:20 @ AthensSymposium on Novel Jet Injection Technology for Influenza Vaccination
15:20-15:50Title: Next generation needle-free injection systemsChris Cappello, PharmaJet Inc, USA
15:50-16:20Title: Post-marketing survey of satisfaction with needle-free administration of Afluria® seasonal influenza vaccine in a grocery pharmacy setting using novel jet injectionCharles A Altman, bioCSL, USA
16:20-16:40Title: The principal migration routes of Eurasion birds - With a focus on Israel and Central EuropeMartin Kraft, Philipps University of Marburg, Germany
15:00-16:00 Poster Presentations @ AthensPanel Discussion
Day 3 June 10, 2015Vienna
Track 3: Potential Drug TargetsTrack 5: Mutation and Influenza VirusTrack 11: Influenza: Alternate Treatment MethodsSession Chair: Masayuki Noguchi, Hokkaido University, Japan
10:00-10:20Title: Modulation of the status of influenza infection by Akt peptide inhibitor Akt-inMasayuki Noguchi, Hokkaido University, Japan
10:20-10:40Title: The role of mHealth in the fight against fluBipin Thomas, Global Virus Network, USA
Networking & Refreshments Break 10:40-11:00 @ Foyer
11:00-11:20Title: The Traditional treatment of flu in West Africa (Guinea-Conakry)Sylvain Haba, Centre Des Soins Medico-Tradi-Spirituels Talithakoumi, Guinea Conakry
11:20-11:40Title: Architecture and assembly of type A influenza virus RNA polymeraseYingfang Liu, Chinese Academy of Sciences, China
11:40-12:00Title: Use of BanLec H84T, a molecular-engineered carbohydrate binding protein, as a therapeutic for influenza virus infectionsE Bart Tarbet, Utah State University, USA
Lunch Break 12:00-12:40 @ AthensAward Ceremony
Website: flu.conferenceseries.com/
November 14-16, 2016 San Francisco, USA2nd International Conference on FluBookmark your dates
OMICS Group Inc.2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
OMICS International5716 Corsa Ave., Suite 110, Westlake
Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414
OMICS GroupSEZ Unit, Building No. 20, 9th Floor
APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA
Ph: 040-40131823, [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
October 31- November 02, 2016 San Francisco, USA
2nd International Conference on FluScientific Program
conferenceseries.com
Hosting Organization: Conference Series LLC2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA, Ph: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499
Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499Email: [email protected], [email protected]
Page 10
08:00-09:00 RegistrationsSequoia
Day 1 October 31, 2016
Group PhotoLunch Break : 13:20-14:05 @ Tiburon
Sessions:Flu Vaccines: Current and Novel Approach| Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups | Flu: Immunology & Genetics Session Chair: Donald P Francis, Global Solutions for Infectious Diseases, USA
Session Introduction
14:05-14:30Title: Diverse hosts contributing to the diversity of influenza A virusTracey Goldstein, One Health Institute, University of California, USA
14:30-14:55Title: IL-15-dependent generation of lung tissue-resident memory CD4 T cellsK Kai Mckinstry, University of Central Florida, USA
14:55-15:20Title: Memory CD4 T cell regulation of innate lymphoid cells during protective responses against influenza A virusTara M Strutt, University of Central Florida, USA
15:20-15:45Title: Targeting the influenza A virus M2 proton channel to combat drug resistanceJun Wang, University of Arizona, USA
Special Session
15:45-16:15Title : Regulation of acute inflammation by memory CD4 T cells during IAV infectionTara M Strutt, University of Central Florida, USA
Networking and Refreshment Break 16:15-16:30 @ FoyerPanel Discussion
Opening Ceremony 09:00-09:30 conferenceseries.com
Keynote Forum
09:30-09:35 Introduction
09:35-10:10 Title: WHO technology transfer activities for influenza vaccines Donald P Francis, Global Solutions for Infectious Diseases, USA10:10-10:45 Title: Drug development from bacterial pathogens to fight infections and cancer Ananda M Chakrabarty, University of Illinois College of Medicine, USA10:45-11:20 Title: Universal therapeutic vaccine against influenza Marek Malecki, Phoenix Biomolecular Engineering Foundation, USA
11:35-12:10 Title: The human viral challenge model: Accelerating drug and vaccine development Anthony S Gilbert, hVIVO, UK
12:10-12:45 Title: Metadichol® a novel ICAM-1 inhibitor Palayakotai Raghavan, Nanorx Inc, USA
12:45-13:20 Title: FDA approved recombinant influenza vaccine Flublok protects against drift influenza viruses Manon M J Cox, Protein Sciences, USA
Networking and Refreshment Break : 11:20-11:35 @ Foyer
Page 11
Day 2 November 01, 2016
Sequoia
Keynote Forum09:30-10:05 Title: Calcium folate for flu prevention and control Phillip Bertrand Berkey Moheno, SanRx Pharmaceuticals Inc., USA
10:05-10:40 Title: Innate defense mechanisms, cell death and survival, signalling and proliferation: The search for new anti-viral targets for influenza A virus Sunil K Lal, Monash University, Malaysia
Networking and Refreshment Break 10:40-10:55 @ FoyerSessions:Pathology of Influenza Virus Infections | Flu Symptoms & Treatment | Flu Clinical Studies & Case Reports | Antivirals and TherapeuticsSession Chair: Donald P Francis, Global Solutions for Infectious Diseases, USASession Co-Chair: Palayakotai Raghavan, Nanorx Inc, USA
Session Introduction
10:55-11:20Title: Dramatic changes in the development and supply of vaccines for the worldDonald P Francis, Global Solutions for Infectious Diseases, USA
11:20-11:45Title: Hemagglutinin receptor-binding specificity of H10N7 avian influenzaTony Velkov, Monash University, Australia
11:45-12:10Title: Another look at what role in 2005-2007 global spread of H5N1 played an upregulation by host cell dioxin of gene encoding type a influenza virus NS1 binding protein Ilya B Tsyrlov, XENOTOX Inc, USA
Young Researcher Forum
12:10-12:35Title: Targeting the influenza RNA-dependent RNA polymeraseDiane Beylkin, SRI International, USA
12:35-13:00Title: Identification and characterization of influenza variants resistant to a viral endonuclease inhibitorGyanendra Kumar, St. Jude Children’s Research Hospital, USA
Lunch Break : 13:00-13:45 @ Tiburon
13:45-14:10Title : Pregnancy and severity of infection with pandemic influenza A(H1N1)pdm09virusNatalia Periolo, INEI-ANLIS "Carlos G. Malbran", Argentina
14:10-14:35Title : Can altering humidity reduce transmission of respiratory viruses: A pilot study in preschool classroomsJennifer M Reiman, Mayo Clinic, USA
14:35-15:00Title : Avian influenza A H7N9 virus efficiently infects and induces apoptosis in human CD14+ monocytes Andrew Chak Yiu Lee, The University of Hong Kong, Hong Kong
15:00-15:25Title : Impaired mouse beta-defensin 4 response to A(H1N1)09 influenza virus challenge results in severe infection in respiratory tract of senescent miceZhu Houshun, The University of Hong Kong, Hong Kong
Networking and Refreshment Break 15:25-15:40 @ FoyerPoster Presentations 15:40-16:40
FLU-01Title: Impact on the need for hospital care, intensive care and mortality of a mass vaccination campaign against 2009 A(H1N1) pandemic influenza in Uppsala county SwedenStaffan P E Sylvan, Uppsala University Hospital, Sweden
FLU-02Title: TLR7 agonist imiquimod enhances the efficacy of 2009 pandemic H1N1 vaccine in BALB/c miceLi Can, The University of Hong Kong, Hong Kong
FLU-03Title: Assessing the performance of rapid influenza diagnostics tests in the communityCandice Keane, University College London, UK
Page 12
FLU-04Title: Assessment of changes in sex hormones, cortisol and white blood cells during menstrual cycle in female asthmatic students at NAU, Nnewi, NigeriaNkiruka Rose Ukibe, Nnamdi Azikiwe University, Nigeria
FLU-05Title: Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory virus infection in vitro and in vivoZhanqiu Yang, Wuhan University, China
Day 3 November 02, 2016
SequoiaSessions:Surveillance Issues and Burden of DiseaseSession Chair: Phillip B Berkey Moheno, SanRx / CSU USA
10:00-10:25Title: Impact of umifenovir use on the reduction secondary bacterial pneumonia following influenzaIrina Leneva, I.Mechnikov Institute for Vaccines and Sera, Russia
Networking and Refreshment Break 10:25-10:45 @ Foyer
10:45-11:10Title: Antiviral activity and possible mechanisms of action of Acacia nilotica against influenza A virusMona Timan Idriss Gassab, Sudan International University, Sudan
Panel DiscussionAward & Closing Ceremony
Lunch Break 12:30-1:30 @ Tiburon
Bookmark your dates
e-mail: [email protected], [email protected]: http://flu.conferenceseries.com/
Conference Series LLC2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
Conference Series Ltd.Traian Str., No.61, Constanta 900720,
Romania, Tel: 0805-080048Heathrow Stockley Park Lakeside
House, 1 Furzeground Way, Heathrow, UB11 1BD, United Kingdom
OMICS International6th Floor, North Block, Divyasree
Building, Raidurg Hyderabad, Telangana, INDIA-500032
Tel: [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
October 30-November 01, 2017 Las Vegas, USA
3rd International Conference on
Flu & Emerging Infectious Diseases